| Name | Title | Contact Details |
|---|
Johnson & Johnson is a multinational healthcare company founded in 1886 in New Brunswick, New Jersey. The company is dedicated to improving human health and well-being through its innovative products and services. Johnson & Johnson operates in three main segments. The Consumer Health segment includes popular brands like Band-Aids, Tylenol, and Johnsons baby products, offering a variety of personal care and over-the-counter medications. The Pharmaceuticals division develops prescription drugs across therapeutic areas such as immunology, infectious diseases, and oncology. Lastly, the Medical Devices segment focuses on creating and manufacturing devices and diagnostics for surgical procedures, orthopedics, and vision care. The companys products cater to a wide audience, including consumers, healthcare professionals, and medical institutions, ensuring accessibility and support for various health needs.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Founded in 1904, the Fédération Internationale de Football Association (FIFA) is the umbrella organisation of its members, currently 211 national football associations. Its main objectives, enshrined in its statutes, are to develop football around the world, to stage international competitions and to protect the integrity of football (against match manipulation, doping etc.). FIFA is composed of a number of political bodies (such as the FIFA Congress and the FIFA Council) and the administration. The highest political position is the FIFA President, elected every four years by FIFAs member associations. The FIFA administration, with more than 800 people from over 60 nations, is based in Zurich. It is run by the Secretary General (CEO). FIFA stages FIFA World Cups™ in various forms such as youth, mens and womens, futsal, beach soccer or club competitions. The mens FIFA World Cup™ is not only the most popular single sporting event in the world but also the financial backbone for FIFA and its efforts to develop football worldwide. The financial success of the FIFA World Cup™ allows FIFA to run a wide range of football development programmes and to provide funds, infrastructure and know-how to its member associations through the FIFA Forward Development Programme. For more information visit our website.
Fair. Rude. But fair. Lets take the second question first. In competitive cycling, Domestiques are riders who lead the pack, breaking headwinds to make the journey easier for the team. And its the love of doing the hard, foundational, gritty and unglamorous work that informs everything we do. Now, to your first question. Domestique is a management consultant company that helps businesses scale through go-to-market operations (aka Revenue Operations or RevOps). Not sure what that answer means? No sweat. We, in the next paragraph. will make it as long-winded as possible. We are Rhys Williams and Alex Biale, co-founders of Domestique. We have a combined 25+ years in go-to-market operations experience, translating CEO questions like "lets move up market" and "lets expand internationally" into best-in-class operations. Our expertise informed the development of a GTM operational framework that we use to help companies create, accelerate and optimize their revenue engines. And our understanding of building, scaling, funding and preparing your company for exit is what sets our expertise apart. Our mission? Empower your business to unlock growth levers to do great things. (What are growth levers? Theyre things like Capacity Planning, Lead Scoring, Customer Segmentation, Comp Strategy, and other terms that sound like things we just made up). Growing a business is hard and too often companies fail because they lack the preparation, agility and connective tissue to get through the hard part. We help by though strategic and technical services to align your business strategy with your go-to-market playbook. Because visualizing your goals, your outcomes and life-changing moments—thats where you come in. Getting you from mile marker to mile marker—thats where we come in. After all, thats our role as your Domestique—Your accelerator. Your guide. Your teammate.